Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Effects of modafinil and R-modafinil on brain stimulation reward thresholds: implications for their use in the treatment of psychostimulant dependence.

Burrows BT, Watterson LR, Johnson MA, Olive MF.

J Drug Alcohol Res. 2015 Dec;4. pii: 235958. Epub 2015 Dec 29.

2.

Examining the Frequency of Stimulant Misuse among Patients with Primary Disorders of Hypersomnolence: A Retrospective Cohort Study.

Mantyh WG, Auger RR, Morgenthaler TI, Silber MH, Moore WR.

J Clin Sleep Med. 2016 May 15;12(5):659-62. doi: 10.5664/jcsm.5788.

3.

A rare case modafinil dependence.

Krishnan R, Chary KV.

J Pharmacol Pharmacother. 2015 Jan-Mar;6(1):49-50. doi: 10.4103/0976-500X.149149.

4.

R-modafinil attenuates nicotine-taking and nicotine-seeking behavior in alcohol-preferring rats.

Wang XF, Bi GH, He Y, Yang HJ, Gao JT, Okunola-Bakare OM, Slack RD, Gardner EL, Xi ZX, Newman AH.

Neuropsychopharmacology. 2015 Jun;40(7):1762-71. doi: 10.1038/npp.2015.24. Epub 2015 Jan 23.

5.

Armodafinil-induced wakefulness in animals with ventrolateral preoptic lesions.

Vetrivelan R, Saper CB, Fuller PM.

Nat Sci Sleep. 2014 May 2;6:57-63. doi: 10.2147/NSS.S53132. eCollection 2014 May 2.

6.

Predicting abuse potential of stimulants and other dopaminergic drugs: overview and recommendations.

Huskinson SL, Naylor JE, Rowlett JK, Freeman KB.

Neuropharmacology. 2014 Dec;87:66-80. doi: 10.1016/j.neuropharm.2014.03.009. Epub 2014 Mar 22. Review.

7.

Psychostimulants and cognition: a continuum of behavioral and cognitive activation.

Wood S, Sage JR, Shuman T, Anagnostaras SG.

Pharmacol Rev. 2013 Dec 16;66(1):193-221. doi: 10.1124/pr.112.007054. Print 2014. Review.

8.

Modafinil as a catecholaminergic agent: empirical evidence and unanswered questions.

Wisor J.

Front Neurol. 2013 Oct 7;4:139. doi: 10.3389/fneur.2013.00139. Review.

9.

The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders.

Mereu M, Bonci A, Newman AH, Tanda G.

Psychopharmacology (Berl). 2013 Oct;229(3):415-34. doi: 10.1007/s00213-013-3232-4. Epub 2013 Aug 10. Review.

10.

The effect of modafinil on fatigue, cognitive functioning, and mood in primary brain tumor patients: a multicenter randomized controlled trial.

Boele FW, Douw L, de Groot M, van Thuijl HF, Cleijne W, Heimans JJ, Taphoorn MJ, Reijneveld JC, Klein M.

Neuro Oncol. 2013 Oct;15(10):1420-8. doi: 10.1093/neuonc/not102. Epub 2013 Aug 7.

12.

Agonist replacement for stimulant dependence: a review of clinical research.

Stoops WW, Rush CR.

Curr Pharm Des. 2013;19(40):7026-35. Review.

13.

Dependence on supratherapeutic doses of modafinil: a case report.

Kate N, Grover S, Ghormode D.

Prim Care Companion CNS Disord. 2012;14(5). pii: PCC.11l01333. doi: 10.4088/PCC.11l01333. Epub 2012 Oct 18. No abstract available.

14.

A practical guide to the therapy of narcolepsy and hypersomnia syndromes.

Mignot EJ.

Neurotherapeutics. 2012 Oct;9(4):739-52. doi: 10.1007/s13311-012-0150-9. Review.

15.

Interactions between modafinil and cocaine during the induction of conditioned place preference and locomotor sensitization in mice: implications for addiction.

Shuman T, Cai DJ, Sage JR, Anagnostaras SG.

Behav Brain Res. 2012 Dec 1;235(2):105-12. doi: 10.1016/j.bbr.2012.07.039. Epub 2012 Aug 3.

16.

R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse.

Loland CJ, Mereu M, Okunola OM, Cao J, Prisinzano TE, Mazier S, Kopajtic T, Shi L, Katz JL, Tanda G, Newman AH.

Biol Psychiatry. 2012 Sep 1;72(5):405-13. doi: 10.1016/j.biopsych.2012.03.022. Epub 2012 Apr 25.

17.

A double-blind, placebo-controlled trial of modafinil for cocaine dependence.

Dackis CA, Kampman KM, Lynch KG, Plebani JG, Pettinati HM, Sparkman T, O'Brien CP.

J Subst Abuse Treat. 2012 Oct;43(3):303-12. doi: 10.1016/j.jsat.2011.12.014. Epub 2012 Feb 27.

18.

Agonist replacement therapy for cocaine dependence: a translational review.

Rush CR, Stoops WW.

Future Med Chem. 2012 Feb;4(2):245-65. doi: 10.4155/fmc.11.184. Review.

19.

Modulation of fronto-cortical activity by modafinil: a functional imaging and fos study in the rat.

Gozzi A, Colavito V, Seke Etet PF, Montanari D, Fiorini S, Tambalo S, Bifone A, Zucconi GG, Bentivoglio M.

Neuropsychopharmacology. 2012 Feb;37(3):822-37. doi: 10.1038/npp.2011.260. Epub 2011 Nov 2.

20.

Review of pharmacological treatment in mood disorders and future directions for drug development.

Li X, Frye MA, Shelton RC.

Neuropsychopharmacology. 2012 Jan;37(1):77-101. doi: 10.1038/npp.2011.198. Epub 2011 Sep 7. Review.

Supplemental Content

Support Center